CHICAGO (AP) — The drugmaker AbbVie said Tuesday it is having second thoughts about its deal to combine with British counterpart Shire after the U.S. government created new limitations on the tax benefits of incorporating overseas.
North Chicago, Illinois-based AbbVie Inc. said it notified Shire that its board intends to reconsider the recommendation it made in July that its shareholders back the proposed combination worth roughly $55 billion.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.